Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity

被引:33
作者
Manjunatha, M. R. [1 ]
Shandil, Radha [2 ,8 ]
Panda, Manoranjan [1 ]
Sadler, Claire [3 ]
Ambady, Anisha [4 ]
Panduga, Vijender [2 ]
Kumar, Naveen [2 ]
Mahadevaswamy, Jyothi [4 ]
Sreenivasaiah, M. [1 ]
Narayan, Ashwini [4 ]
Guptha, Supreeth [4 ]
Sharma, Sreevalli [4 ]
Sambandamurthy, Vasan K. [4 ]
Ramachandran, Vasanthi [4 ]
Mallya, Meenakshi [1 ]
Cooper, Christopher [5 ]
Mdluli, Khisi [5 ]
Butler, Scott [6 ]
Tommasi, Ruben [6 ]
Iyer, Pravin S. [1 ]
Narayanan, Shridhar [4 ,8 ]
Chatterji, Monalisa [4 ]
Shirude, Pravin S. [1 ,7 ]
机构
[1] AstraZeneca India, Dept Med Chem, IMED Infect, Bellary Rd, Bangalore 560024, Karnataka, India
[2] AstraZeneca, DMPK & Anim Sci, IMED Infect, Bangalore 560024, Karnataka, India
[3] AstraZeneca, Safety Assessment, IMED, Alderly Pk, Mereside, England
[4] AstraZeneca, IMED Infect, Dept Biosci, Bangalore 560024, Karnataka, India
[5] Global Alliance TB, New York, NY 10005 USA
[6] AstraZeneca, GHP, Infect IMED, Waltham, MA 02451 USA
[7] Biocon Bristol Myers Squibb Res & Dev Ctr, Bommasandra Jigani Link Rd, Bangalore 560099, Karnataka, India
[8] Fdn Neglected Dis Res, 20A KIADB Ind Area, Bengaluru 561203, India
关键词
DprE1; Mycobacterium tuberculosis; azaindole; benzimidazole; KILL MYCOBACTERIUM-TUBERCULOSIS; ARABINAN; MODEL;
D O I
10.1021/acsmedchemlett.9b00343
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report a novel benzimidazole (BI) based DprE1 inhibitor that resulted from scaffold morphing of a 1,4-azaindole series. The clinical progression of the 1,4-azaindole series from our previous work validates the potential of exploring newer chemical entities with antimycobacterial activity driven via a noncovalent inhibition of the decaprenylphosphoryl-beta-D-ribose-2'-epimerase (DprE1). The representative compounds from the new scaffold reported in this study exhibited an improved solubility and higher free plasma fraction, while retaining potent DprE1 inhibition and antimycobacterial activity. A representative compound from the benzimidazole series demonstrated good efficacy in a murine model of tuberculosis. Furthermore, molecular modeling of the BI scaffold suggests plausible modes of binding in the active site of DprE1 enzyme from Mycobacterium tuberculosis that can be used for further exploration of the series.
引用
收藏
页码:1480 / 1485
页数:11
相关论文
共 16 条
[1]  
[Anonymous], GLOB TUB REP 2018
[2]  
[Anonymous], SMALL MOL DRUG DISC
[3]   Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors [J].
Batt, Sarah M. ;
Jabeen, Talat ;
Bhowruth, Veemal ;
Quill, Lee ;
Lund, Peter A. ;
Eggeling, Lothar ;
Alderwick, Luke J. ;
Fuetterer, Klaus ;
Besra, Gurdyal S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (28) :11354-11359
[4]   1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis [J].
Chatterji, Monalisa ;
Shandil, Radha ;
Manjunatha, M. R. ;
Solapure, Suresh ;
Ramachandran, Vasanthi ;
Kumar, Naveen ;
Saralaya, Ramanatha ;
Panduga, Vijender ;
Reddy, Jitendar ;
Prabhakar, K. R. ;
Sharma, Sreevalli ;
Sadler, Claire ;
Cooper, Christopher B. ;
Mdluli, Khisi ;
Iyer, Pravin S. ;
Narayanan, Shridhar ;
Shirude, Pravin S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) :5325-5331
[5]   Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis [J].
Chikhale, Rupesh V. ;
Barmade, Mahesh A. ;
Murumkar, Prashant R. ;
Yadav, Mange Ram .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) :8563-8593
[6]   Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs against Mycobacterium tuberculosis [J].
De Groote, Mary A. ;
Gilliland, Janet C. ;
Wells, Colby L. ;
Brooks, Elizabeth J. ;
Woolhiser, Lisa K. ;
Gruppo, Veronica ;
Peloquin, Charles A. ;
Orme, Ian M. ;
Lenaerts, Anne J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) :1237-1247
[7]   Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes [J].
Friesner, Richard A. ;
Murphy, Robert B. ;
Repasky, Matthew P. ;
Frye, Leah L. ;
Greenwood, Jeremy R. ;
Halgren, Thomas A. ;
Sanschagrin, Paul C. ;
Mainz, Daniel T. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) :6177-6196
[8]   Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis [J].
Jayaram, R ;
Gaonkar, S ;
Kaur, P ;
Suresh, BL ;
Mahesh, BN ;
Jayashree, R ;
Nandi, V ;
Bharat, S ;
Shandil, RK ;
Kantharaj, E ;
Balasubramanian, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2118-2124
[9]   Towards a new combination therapy for tuberculosis with next generation benzothiazinones [J].
Makarov, Vadim ;
Lechartier, Benoit ;
Zhang, Ming ;
Neres, Joao ;
van der Sar, Astrid M. ;
Raadsen, Susanne A. ;
Hartkoorn, Ruben C. ;
Ryabova, Olga B. ;
Vocat, Anthony ;
Decosterd, Laurent A. ;
Widmer, Nicolas ;
Buclin, Thierry ;
Bitter, Wilbert ;
Andries, Koen ;
Pojer, Florence ;
Dyson, Paul J. ;
Cole, Stewart T. .
EMBO MOLECULAR MEDICINE, 2014, 6 (03) :372-383
[10]   Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis [J].
Makarov, Vadim ;
Manina, Giulia ;
Mikusova, Katarina ;
Moellmann, Ute ;
Ryabova, Olga ;
Saint-Joanis, Brigitte ;
Dhar, Neeraj ;
Pasca, Maria Rosalia ;
Buroni, Silvia ;
Lucarelli, Anna Paola ;
Milano, Anna ;
De Rossi, Edda ;
Belanova, Martina ;
Bobovska, Adela ;
Dianiskova, Petronela ;
Kordulakova, Jana ;
Sala, Claudia ;
Fullam, Elizabeth ;
Schneider, Patricia ;
McKinney, John D. ;
Brodin, Priscille ;
Christophe, Thierry ;
Waddell, Simon ;
Butcher, Philip ;
Albrethsen, Jakob ;
Rosenkrands, Ida ;
Brosch, Roland ;
Nandi, Vrinda ;
Bharath, Sowmya ;
Gaonkar, Sheshagiri ;
Shandil, Radha K. ;
Balasubramanian, Venkataraman ;
Balganesh, Tanjore ;
Tyagi, Sandeep ;
Grosset, Jacques ;
Riccardi, Giovanna ;
Cole, Stewart T. .
SCIENCE, 2009, 324 (5928) :801-804